PubMed: Perceptions and Opinions on Cannabidiol in the Orthopaedic Sports Medicine Community

PubMed: Perceptions and Opinions on Cannabidiol in the Orthopaedic Sports Medicine Community

Orthop J Sports Med. 2023 Sep 21;11(9):23259671231191766. doi: 10.1177/23259671231191766. eCollection 2023 Sep.

ABSTRACT

BACKGROUND: Cannabidiol (CBD) is a known pain modulator that is garnering increased attention in the orthopaedic world. There may be a considerable knowledge gap among orthopaedic sports medicine providers and their perception of its therapeutic value.

PURPOSE: To (1) examine the knowledge and beliefs of sports medicine orthopaedic providers with respect to CBD, (2) deliver an educational component, and (3) elucidate potential barriers to its widespread application.

STUDY DESIGN: Cross-sectional study.

METHODS: A 3-component, 25-question online survey was distributed to members of the American Orthopaedic Society for Sports Medicine and the Arthroscopy Association of North America between July and October 2022. The first 20 questions assessed baseline knowledge and opinions regarding CBD, followed by an educational component, and then 5 questions assessing whether the respondents’ opinions had changed after learning more about CBD. Responses were compared according to age, practice setting, and state’s cannabinoid legalization status using the chi-square test, and changes in opinions from before to after the educational component were compared using the paired t test.

RESULTS: There were 101 survey responses, for a response rate of approximately 1%. Most respondents believed that there is a role for CBD in postoperative pain management (76%), acute pain and inflammation after an injury (62%), and chronic pain (94%). Most respondents admitted that they were not knowledgeable about the mechanism of action (89%) or their state’s laws (66%) concerning CBD. A minority (25%) believed that CBD has psychoactive properties. While most respondents (76%) did not believe that they would be stigmatized if they were to suggest CBD to a patient, only 48% had ever suggested CBD. Notably, 94% of respondents had encountered patients who reported trying CBD to treat pain. After reading the fact sheet, 51% of respondents stated that their opinion on CBD had changed, and 63% felt inclined to investigate the topic further.

CONCLUSION: Most survey respondents believed that CBD has a role in postoperative and chronic pain management. Although there was a relative familiarity with CBD, there was a knowledge gap, suggesting that increased attention, education, and research are necessary.

PMID:37745814 | PMC:PMC10517622 | DOI:10.1177/23259671231191766

https://pubmed.ncbi.nlm.nih.gov/37745814/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1NqsX9BbHlDygQ8TcgAlJilHgPpiuKQtyIr–a3-xbLzPoB9xM&fc=20220928170152&ff=20230925190615&v=2.17.9.post6+86293ac September 25, 2023 10:00 am